Soliton to Present Pivotal Cellulite Clinical Trial Results at AAD on March 21, 2020

Grand Junction Sentinel

Mar 3, 2020

HOUSTON, March 3, 2020 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology license…